To strengthen our findings, HSPB6 was knocked down in the 22Rv1 cell line, which yielded similar results, supporting the role of HSPB6 in promoting apoptosis in prostate cancer cells (Supplementary Fig. 2C–N). This evidence concerns the gene HSPB6 and prostate carcinoma.